TrialScope Data Transparency Platform for Clinical Trials

TrialScope is a clinical trial management platform that ensures compliance processes are consistently implemented while optimising disclosure activities and trial data transparency.

This flexible and customisable platform is designed to inform and engage patients through open research sharing. It supports clinical trial disclosure and transparency, from registration to final report summaries.

TrialScope improves patient recruitment and engagement, as well as promotes simplified and validated data-sharing across all of its corporate websites. The platform is intuitive, easy-to-use, and connects data in real-time, which ensures that trial information is promptly displayed for both internal and public viewing.

TrialScope is currently used in 40% of industry trials registered on ClinicalTrials.gov and EudraCT. Today, more than 12,000 users manage more than 30,000 clinical trials using TrialScope’s technologies.

Clinical trial disclosure and registration software

TrialScope DiscloseTM centralises, tracks and registers clinical trial data in compliance with disclosure processes. The system mitigates compliance risks and provides greater control over disclosure reputation.

The platform’s comprehensive, Cloud-based software includes a full range of capabilities for compliant, confident clinical trial disclosure, from protocol to registration to results.

Turnkey clinical trials website solution for patients

TrialScope EngageTM enables clinical trial sponsors to engage with patients and the public via a user-friendly, high-impact website.

The site openly shares clinical trial information and results, demonstrating leadership in transparency. It also optimises recruitment and patient retention.

TrialScope Engage enables sponsors to deliver clear communications via the clinical trial publication website, and ensuring only pre-approved and accurate trial information is shared using real-time connectivity to ClinicalTrials.gov and TrialScope Disclose platforms.

Disclosure advisory services for data-driven evaluation

TrialScope is one of the most widely used global clinical trial disclosure and transparency management platforms in the world. It offers disclosure services that can be used in conjunction with the platform’s state-of-the-art software to make disclosure efforts more accurate and efficient.

The services are scalable, so clients can adjust the parameters to accommodate their changing workload.

Utilising an established, data-driven evaluation methodology, TrialScope’s advisory services provide clinical trial sponsors with vital disclosure and transparency reviews and recommendations. These prepare sponsors for pending inspections and help improve assessment results.

TrialScope’s experts offer concrete metrics and best practice recommendations to achieve compliant, efficient clinical trial disclosure that also meets evolving transparency trends.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

TrialScope Engage is One of PM360’s Most Innovative Healthcare Services of 2018

Leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device and diagnostics industries PM360 selected TrialScope’s clinical trial transparency service known as TrialScope Engage as one of the most innovative services of 2018 in the life sciences industry.

Product and Services
White Papers

Disclosure as a Service Case Study: Small Biotech Firm Manages Disclosure

Learn how a small but growing biotech company manages disclosure, maintains compliance and keeps its promise to patients with TrialScope's Disclosure as a Service.

Address
TrialScope

Harborside Financial Center

Plaza Five, Suite 2900

Jersey City

07311

New Jersey

United States of America

TrialScope Images

Press Release

17 April 2019

Leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device and diagnostics industries PM360 selected TrialScope’s clinical trial transparency service known as TrialScope Engage as one of the most innovative services of 2018 in the life sciences industry.

Read more
10 April 2019

TrialScope’s strategic partnership with nonprofit organization Vivli offers sponsors and researchers access to the most complete solution for disclosure and data sharing.

Read more
3 April 2019

TrialScope has been named a finalist for Best Patient-Focused Technological Development in the CARE Awards, which recognise outstanding work across the global clinical research enterprise.

Read more
10 April 2016

TrialScope has been recognised by CIOReview as one of 2016's 20 Most Promising Pharma and Life Sciences Tech Solution Providers.

Read more
17 December 2015

TrialScope has recently conducted its Clinical Trial Transparency Leadership Forum, as part of its Transparency Leadership series.

Read more
13 October 2015

TrialScope will be in Philadelphia for the CBI Prep Forum for the New EU Clinical Trial Regulation.

Read more
5 June 2015

TrialScope has announced it has relocated its headquarters to a larger space that accommodates the rapid growth the company has experienced and the expected growth in the next few years.

Read more
8 April 2015

TrialScope has announced the release of Convert, a free online clinical trial data conversion service.

Read more
29 March 2015

TrialScope has announced two executive appointments. Brian Flaherty will be vice-president of Business Development and Thomas Wicks has been appointed chief strategy officer (CSO).

Read more
1 February 2015

Bridge Capital Holdings, whose subsidiary is Bridge Bank, announced it has provided TrialScope with a $2 million revolving credit facility based on monthly recurring revenue.

Read more
8 December 2014

TrialScope has announced general availability of the latest release of the PharmaCM platform v.2.2.

Read more
20 October 2014

TrialScope announced it has appointed Richard Aguinaldo as chief financial officer (CFO).

Read more

Regional Offices

TrialScope, Inc

Harborside Five

185 Hudson Street, Suite 2900

Jersey City, NJ 07311

07311

New Jersey

United States of America

+1 877 658 8310 www.trialscope.com
TrialScope

Harborside Financial Center

Plaza Five, Suite 2900

Jersey City

07311

New Jersey

United States of America

Contact company

I have read and accept the terms and conditions and privacy policys.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.


Go Top